A descriptive comparative project will be conducted to determine if there is a difference in outcomes for adult patients requiring pericardial reconstruction using CorMatrix compared to Gentrix
A descriptive, comparative project will be conducted utilizing a retrospective chart review on patients at Methodist Mansfield Medical Center(MMMC) undergoing cardiac surgery requiring pericardial repair between the dates of January 1, 2017 through December 31, 2022. The project will compare outcomes of a pre- and post-intervention following use of Gentrix ECM and the CorMatrix Extracellular Matrix(ECM) pericardial patch using information gathered from the patient's electronic health record (EHR). The main outcome measures of post-operative Length of Stay(LOS), all-cause unplanned readmission within 30 days, and significant pleural effusion requiring thoracentesis within 30-days and 60 days as well as long-term (12 months) patient outcomes.
Study Type
OBSERVATIONAL
Enrollment
489
To determine feasibility and effectiveness of Gentrix for cardiac use, and if this product is patient population specific.
Clinical Research Institute at Methodist Health System
Dallas, Texas, United States
Methodist Dallas Medical Center
Dallas, Texas, United States
Post-operative hospital LOS
30-day all-cause unplanned readmissions after discharge * Significant pleural effusion requiring thoracentesis within 30 days of surgery * Significant pleural effusion requiring thoracentesis within 60 days of surgery
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.